IFRX
Price
$0.86
Change
-$0.04 (-4.44%)
Updated
Aug 1 closing price
Capitalization
59.62M
3 days until earnings call
TENX
Price
$6.22
Change
-$0.02 (-0.32%)
Updated
Aug 1 closing price
Capitalization
25.8M
Interact to see
Advertisement

IFRX vs TENX

Header iconIFRX vs TENX Comparison
Open Charts IFRX vs TENXBanner chart's image
InflaRx
Price$0.86
Change-$0.04 (-4.44%)
Volume$123.61K
Capitalization59.62M
Tenax Therapeutics
Price$6.22
Change-$0.02 (-0.32%)
Volume$10.29K
Capitalization25.8M
IFRX vs TENX Comparison Chart in %
Loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IFRX vs. TENX commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a Buy and TENX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 04, 2025
Stock price -- (IFRX: $0.86 vs. TENX: $6.22)
Brand notoriety: IFRX and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 22% vs. TENX: 33%
Market capitalization -- IFRX: $59.62M vs. TENX: $25.8M
IFRX [@Biotechnology] is valued at $59.62M. TENX’s [@Biotechnology] market capitalization is $25.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, TENX is a better buy in the long-term than IFRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 1 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • IFRX’s TA Score: 1 bullish, 4 bearish.
  • TENX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TENX is a better buy in the short-term than IFRX.

Price Growth

IFRX (@Biotechnology) experienced а -4.31% price change this week, while TENX (@Biotechnology) price change was +2.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

IFRX is expected to report earnings on Oct 30, 2025.

TENX is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IFRX($59.6M) has a higher market cap than TENX($25.8M). TENX YTD gains are higher at: 0.485 vs. IFRX (-65.182). TENX has higher annual earnings (EBITDA): -24.2M vs. IFRX (-44.22M). TENX has more cash in the bank: 111M vs. IFRX (65.9M). TENX has less debt than IFRX: TENX (279K) vs IFRX (703K). IFRX has higher revenues than TENX: IFRX (130K) vs TENX (0).
IFRXTENXIFRX / TENX
Capitalization59.6M25.8M231%
EBITDA-44.22M-24.2M183%
Gain YTD-65.1820.485-13,449%
P/E RatioN/A3.68-
Revenue130K0-
Total Cash65.9M111M59%
Total Debt703K279K252%
FUNDAMENTALS RATINGS
IFRX vs TENX: Fundamental Ratings
IFRX
TENX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
6542
P/E GROWTH RATING
1..100
10044
SEASONALITY SCORE
1..100
3129

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for IFRX (63) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than IFRX’s over the last 12 months.

TENX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IFRX (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to IFRX’s over the last 12 months.

TENX's SMR Rating (96) in the Medical Specialties industry is in the same range as IFRX (97) in the Biotechnology industry. This means that TENX’s stock grew similarly to IFRX’s over the last 12 months.

TENX's Price Growth Rating (42) in the Medical Specialties industry is in the same range as IFRX (65) in the Biotechnology industry. This means that TENX’s stock grew similarly to IFRX’s over the last 12 months.

TENX's P/E Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for IFRX (100) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than IFRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IFRXTENX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCOEY13.210.35
+2.72%
Capcom Co. Ltd
TDSGF0.06N/A
N/A
Telo Genomics Corp.
BEKAY3.29N/A
N/A
NV Bekaert SA
CDAB17.75N/A
N/A
Coeur D Alene Bancorp
SLVMF0.09-0.01
-5.56%
Silver Mines Ltd., Sydney

IFRX and

Correlation & Price change

A.I.dvisor tells us that IFRX and NNVC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
-4.97%
NNVC - IFRX
30%
Poorly correlated
-2.47%
LXEO - IFRX
28%
Poorly correlated
-2.54%
VERA - IFRX
28%
Poorly correlated
+0.77%
ALLO - IFRX
28%
Poorly correlated
-12.20%
TENX - IFRX
26%
Poorly correlated
-0.32%
More